COMERICA BANK - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 130 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
COMERICA BANK ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$742,739
+123483.9%
16,150
-22.2%
0.00%
-20.0%
Q4 2022$601
-99.9%
20,752
-24.8%
0.01%
-28.6%
Q3 2022$852,000
-23.2%
27,592
-8.9%
0.01%
-22.2%
Q2 2022$1,109,000
-6.0%
30,272
+0.3%
0.01%0.0%
Q1 2022$1,180,000
+37.2%
30,182
-12.6%
0.01%
+50.0%
Q4 2021$860,000
+40.3%
34,517
+8.1%
0.01%
+50.0%
Q3 2021$613,000
+0.5%
31,927
-2.2%
0.00%0.0%
Q2 2021$610,000
-0.7%
32,650
-7.8%
0.00%0.0%
Q1 2021$614,000
-10.9%
35,429
-3.9%
0.00%0.0%
Q4 2020$689,000
-10.3%
36,857
-0.0%
0.00%
-33.3%
Q3 2020$768,000
+7.9%
36,868
+6.8%
0.01%
+20.0%
Q2 2020$712,000
+27.6%
34,533
+3.6%
0.01%0.0%
Q1 2020$558,000
-11.8%
33,334
+1.9%
0.01%0.0%
Q4 2019$633,000
-0.9%
32,728
-0.0%
0.01%0.0%
Q3 2019$639,000
-3.8%
32,742
-1.2%
0.01%0.0%
Q2 2019$664,000
-9.0%
33,155
-4.5%
0.01%
-16.7%
Q1 2019$730,000
-2.7%
34,703
+2.1%
0.01%0.0%
Q4 2018$750,000
+20.6%
33,981
-0.4%
0.01%
+20.0%
Q3 2018$622,000
-0.5%
34,120
-10.4%
0.01%
+25.0%
Q2 2018$625,000
-13.3%
38,063
+2.8%
0.00%
-20.0%
Q1 2018$721,000
+2.1%
37,028
+1.3%
0.01%0.0%
Q4 2017$706,000
+3.8%
36,536
-2.5%
0.01%0.0%
Q3 2017$680,000
+2.3%
37,490
-0.0%
0.01%0.0%
Q2 2017$665,000
+10.8%
37,492
-5.4%
0.01%0.0%
Q1 2017$600,000
-8.0%
39,612
+4.1%
0.01%0.0%
Q4 2016$652,000
-3.6%
38,042
+7.4%
0.01%
-16.7%
Q3 2016$676,00035,4140.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders